Projected Depo Provera Lawsuit Settlements
- Last Updated: June 3rd, 2025
Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Key takeaways:
- Depo-Provera, an injectable contraceptive manufactured by Pfizer Inc., has been linked to an increased risk of developing meningiomas (brain tumors), leading to several lawsuits filed against the company.
- A large national case-control study conducted using the French National Health Data System found a significantly elevated risk of meningiomas associated with prolonged exposure to synthetic progestogens, such as the primary ingredient in Depo-Provera.
- An experienced attorney at TruLaw can help assess cases, guide evidence collection, and work to secure potential compensation for damages, including medical expenses, lost wages, pain and suffering, and loss of consortium.
Potential Depo-Provera Lawsuit Settlement Amounts
The link between Depo-Provera birth control and an increased risk of developing meningiomas (brain tumors) has led to several lawsuits being filed against Pfizer Inc., the manufacturer of the injectable contraceptive.
Legal experts estimate that the Depo-Provera lawsuit settlement amounts will likely range between $100,000 and $500,000 or more based on various factors specific to your circumstances, such as the length of taking Depo-Provera and severity of damages or injuries.
On this page, we’ll provide estimated Depo-Provera lawsuit settlement amounts, an overview of the Depo-Provera lawsuit, research linking Depo-Provera and meningiomas (brain tumors), and much more.
Estimated Depo-Provera Lawsuit Settlement Tiers
Estimated settlements for Depo-Provera lawsuits will vary widely depending on factors such as the severity of the tumor, the impact on Depo-Provera users’ quality of life, and the necessary treatments.
It’s important to note that the projections discussed below are strictly intended to give affected individuals a general idea of what these settlement values could look like if claims are successful — as the Depo-Provera litigation progresses, more accurate estimates may become available.
Settlement amounts in cases similar to the Depo-Provera lawsuit are typically categorized into the following tiers:
- Tier One ($300,000 – $500,000): Applies to severe, life-threatening cases such as malignant (Grade III) meningiomas that require extensive treatment (surgery, radiation, or chemotherapy). Plaintiffs often face lasting neurological effects, high medical expenses, and long-term health impacts.
- Tier Two ($200,000 – $300,000): Covers non-cancerous but aggressively growing Grade II meningiomas with a high recurrence risk, typically requiring surgery, radiation, and ongoing monitoring. Plaintiffs may experience significant lifestyle changes and prolonged health oversight.
- Tier Three ($100,000 – $200,000): Pertains to slow-growing, non-cancerous Grade I meningiomas that, while less severe, still necessitate medical intervention. Compensation here addresses diagnostic costs, surgery, and disruptions to work or daily life.
Additional factors influencing the settlement amounts include the plaintiff’s ability to establish a direct connection between Depo-Provera and the brain tumor and the plaintiff’s ability to demonstrate that Pfizer neglected to provide sufficient warnings.
If you were diagnosed with a meningioma after receiving Depo-Provera injections, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine your eligibility to join others in filing a Depo-Provera lawsuit today.
Table of Contents
How Can a Depo-Provera Attorney from TruLaw Help You?
At TruLaw, our dedicated attorneys, led by Jessica Paluch, specialize in advocating for individuals affected by pharmaceutical issues, including those related to Depo-Provera.
With a strong background in pharmaceutical litigation, Jessica Paluch is well-equipped to handle complex cases involving dangerous drugs.
She and our team at TruLaw are committed to providing personalized legal guidance and support to ensure that clients receive the compensation they deserve.
Our approach involves a thorough case evaluation to determine the best action for each client’s unique situation.
We leverage our extensive network of legal partners to provide top-tier representation, ensuring that clients receive the best possible outcomes.
Our focus on client-centered service means that we prioritize open communication and tailored strategies to address each client’s specific needs and goals.
Meet the Lead Depo-Provera Attorney at TruLaw
Meet our lead Depo-Provera attorney:
- Jessica Paluch: As the founder and managing attorney of TruLaw, Jessica brings a wealth of experience in pharmaceutical litigation. She has a proven track record of achieving successful settlements and verdicts for her clients. Jessica’s expertise in navigating intricate legal matters, combined with her commitment to client success, makes her a formidable advocate for those harmed by dangerous drugs like Depo-Provera.
How much does it cost to hire a Depo-Provera lawyer from TruLaw?
At TruLaw, we operate on a contingency fee model, which means that there are no upfront costs for hiring our attorneys.
You only pay if we secure compensation for you.
This approach ensures transparent billing and aligns our interests with yours, as we work to achieve the best possible outcome for your case.
Research Linking Depo-Provera to Meningioma (Brain Tumors)
The research linking Depo-Provera to Meningioma was a large national case-control analysis conducted using the French National Health Data System, which includes over 108,000 women.
It focused on analyzing 18,061 women who underwent intracranial meningioma surgery from 2009 to 2018, matched with 90,305 control participants based on age and residence.
This national case-control analysis assessed the potential risk of developing intracranial meningiomas associated with various progestogens, such as the active ingredient in Depo-Provera.
Through this design, researchers examined exposure duration and dosage to evaluate if long-term use of specific progestogens influenced the likelihood of requiring surgical intervention for meningiomas.
Grade I Meningiomas (Non-Cancerous)
Grade I meningiomas are the most common form of brain tumors associated with progestogen use, accounting for the majority of benign, slow-growing meningiomas found in this study.
Although non-cancerous, these tumors can press against nearby brain structures, causing neurological symptoms that often necessitate surgery.
The study identified a higher incidence of Grade I meningiomas in women with prolonged exposure to medroxyprogesterone acetate, especially those using it as a contraceptive.
These findings underscore the need for monitoring patients who are long-term users of such progestogens, as even benign tumors can significantly impact health due to their location and size.
Grade II Meningiomas (Non-Cancerous but Atypical)
Grade II meningiomas, though also non-cancerous, are atypical and have a higher recurrence rate after treatment compared to Grade I.
This study observed that prolonged exposure to medroxyprogesterone acetate correlated with an increased likelihood of developing these atypical meningiomas.
Due to their propensity to regrow, Grade II meningiomas often require more intensive monitoring and, in some cases, additional treatment.
The increased risk associated with long-term progestogen use raises considerations for patients using Depo-Provera, as atypical tumors can lead to more complex health outcomes over time.
Grade III Meningiomas (Cancerous)
Grade III meningiomas are malignant and aggressive, though they were the least observed tumor type in the study among users of medroxyprogesterone acetate.
While no direct association was identified between progestogen exposure and the development of malignant meningiomas, the study’s findings emphasize the importance of further investigation.
The link between progestogen exposure and the more common, non-cancerous meningiomas suggests that long-term hormonal influence may still play a role in tumor progression for certain patients.
If you or a loved one suffered severe side effects after receiving the Depo-Provera birth control shot, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo-Provera brain tumor lawsuit today.
How to File a Depo-Provera Lawsuit
Filing a claim in the Depo-Provera meningioma lawsuits against Pfizer for Depo-Provera requires careful planning and gathering of critical evidence.
Plaintiffs claim that Depo-Provera’s use, particularly its prolonged exposure, has been linked to an increased risk of brain tumors, notably meningiomas.
Studies from the French National Health Data System indicate a significantly elevated risk of meningiomas associated with synthetic progestogens, particularly after prolonged exposure (≥ one year) to specific progestins, such as medroxyprogesterone acetate (the primary ingredient in Depo-Provera).
An experienced legal team will help assess your case, guide evidence collection, and work to secure potential compensation for damages.
Eligibility Criteria for Plaintiffs
To qualify for a Depo-Provera lawsuit, plaintiffs must meet specific eligibility criteria.
Potential plaintiffs should have experienced significant health complications attributed to the prolonged use of Depo-Provera.
According to recent research, exposure to high-dose progestogens, including medroxyprogesterone acetate, correlates with an increased risk of surgically treated meningiomas, especially among older women.
Eligibility factors in the Depo-Provera lawsuit may include:
- Prolonged Use of Depo-Provera: Documented use of Depo-Provera, especially for one year or longer.
- Meningioma Diagnosis: Diagnosis of a meningioma, ideally with records showing tumor grade and symptoms caused by the tumor.
- Treatment Records: Documentation of surgeries, radiation, or other treatments required due to the tumor.
- Impact on Life and Work: Evidence of how the tumor affected daily life, work capabilities, or income.
- Medical Records of Related Complications: Additional health records showing other neurological or cognitive complications that developed post-use.
Potential plaintiffs should consult a specialized attorney to confirm eligibility and understand the specific requirements based on individual case facts and the growing body of scientific evidence linking Depo-Provera and meningiomas.
Building a Strong Case: Evidence Collection
Collecting evidence is a fundamental part of building a compelling case against Pfizer.
Since meningioma cases related to Depo-Provera involve detailed medical histories and expert testimony, the evidence must be comprehensive and precise.
Studies have found that in cases where Depo-Provera and other synthetic progestogens were linked to meningiomas, the tumors were often located in high-risk areas, such as the skull base, and presented significant surgical challenges.
Key types of evidence include:
- Medical Records: Provide records detailing the Depo-Provera prescription, diagnosis of meningioma, and any treatment plans, including surgeries, radiation, or medications.
- Prescription History: Document your history of Depo-Provera usage, noting dosage, frequency, and any doctor visits specifically concerning its prescription.
- Scientific Research Supporting Claims: Reference relevant studies, such as the recent French national case-control study, which links prolonged exposure to progestogens, including medroxyprogesterone acetate, with an elevated risk of developing intracranial meningioma.
- Personal Impact Documentation: Include records of how the tumor affected daily life and work, such as employment records showing time off or income loss.
- Expert Testimony: In situations where medical expertise is beneficial, expert opinions from professionals familiar with the link between Depo-Provera and meningiomas can strengthen the claim.
Assembling these elements with the support of experienced legal representation can significantly improve the strength of your lawsuit and your chances of receiving fair compensation.
If you or a loved one has been diagnosed with a meningioma after prolonged use of Depo-Provera, you may be eligible for compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to file a Depo-Provera lawsuit.
Damages in Depo-Provera Lawsuits
Patients who develop meningiomas linked to Depo-Provera may seek damages in a lawsuit against Pfizer for the physical, emotional, and financial impacts of their diagnosis.
These cases focus on compensating individuals for both immediate and ongoing harm.
In these claims, plaintiffs often present evidence of health complications associated with long-term synthetic hormone exposure, particularly from the active ingredient in Depo-Provera, medroxyprogesterone acetate.
A recent study demonstrated a notable risk increase of meningiomas for those with prolonged progestin exposure, which may serve as essential evidence in supporting claims for damages.
Types of Compensable Damages
If successful, plaintiffs in Depo-Provera lawsuits may be eligible for various types of compensable damages.
These are designed to address the multifaceted impact of meningioma diagnoses and treatment on their lives.
The main categories of compensable damages include:
- Medical Expenses: Covers the cost of diagnostic tests, surgeries, radiation, and other treatments required due to the meningioma.This includes both current and projected future expenses.
- Lost Wages: Compensates for income lost during treatment and recovery periods, including any time required for follow-up visits and therapies.
- Loss of Future Earnings: Provides compensation if the tumor or its treatment limits the plaintiff’s ability to work in the future.
- Pain and Suffering: Addresses the physical and emotional distress caused by the diagnosis, treatments, and potential lifelong impacts of the tumor.
- Loss of Consortium: In some cases, spouses may claim damages for the impact on their marital relationship and family life.
These damages are intended to provide comprehensive financial relief and support the plaintiff’s recovery, acknowledging the profound effects that serious diagnoses like meningiomas can have on personal and professional life.
Factors Influencing Settlement Amounts
Settlement amounts for Depo-Provera lawsuits can vary greatly and be influenced by several factors.
These factors help determine the extent of financial compensation plaintiffs may receive if the case is successful.
Key factors affecting settlement amounts include:
- Severity of the Tumor: Higher settlements may be awarded for malignant or atypical meningiomas (Grade II or III) that require extensive treatment and pose significant health risks.Evidence from the French national study reinforces the potential for higher compensation in cases involving these more serious forms of meningioma.
- Impact on Daily Life and Work: Cases where the meningioma has led to significant cognitive or physical limitations, affecting the plaintiff’s ability to work or perform daily activities, typically resulting in higher settlements.
- Duration and Extent of Depo-Provera Use: Settlement amounts may also depend on the documented duration of Depo-Provera use, with long-term users facing a potentially higher risk and, therefore, more substantial claims for damages.
- Prognosis and Ongoing Treatment Needs: Cases that involve ongoing or indefinite treatment, such as regular imaging, medication, or rehabilitative services, may yield higher compensation due to the enduring financial burden.
- Availability of Supporting Evidence: Scientific research, such as the recent study on progestin-associated meningioma risks, may strengthen individual claims by establishing a documented link between Depo-Provera and meningioma development.
The final settlement amount in Depo-Provera cases will reflect a comprehensive evaluation of these factors, with experienced Depo-Provera lawyers working to ensure that all relevant damages are appropriately compensated.
TruLaw: Your Depo-Provera Law Firm
Depo-Provera lawsuits are being filed by individuals across the country who were diagnosed with meningioma or other severe health conditions after using the contraceptive injection.
TruLaw is currently accepting clients for the Depo-Provera lawsuit.
A few reasons to choose TruLaw for your Depo-Provera lawsuit include:
- If We Don’t Win, You Don’t Pay: The Depo-Provera lawsuit lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
- Expertise: We have years of experience handling pharmaceutical liability cases similar to the Depo-Provera lawsuit, which helps us anticipate what we can expect to see in your case and the regulations we will be required to meet.
- Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.
If you or a loved one were diagnosed with any grade of meningioma or suffered from other severe health conditions after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo-Provera lawsuit today.
Depo-Provera Lawsuit Frequently Asked Questions
-
Is there a Depo-Provera Class Action Lawsuit?
Currently, there is no Depo-Provera class action lawsuit; instead, individual claims are being filed nationwide in federal courts.
These claims could eventually lead to consolidation into a mass tort or multidistrict litigation (MDL), where each case is evaluated individually within a coordinated legal process.
-
Is generic Depo-Provera birth control shot included in the lawsuits?
While the lawsuits primarily focus on the brand-name Depo-SubQ Provera, it’s possible that generic versions could also be included if they are manufactured by Pfizer or if there is evidence that the generic manufacturers failed to provide adequate warnings.
Therefore, if you used a generic version of Depo-Provera and developed a brain tumor or other serious health complications, you should consult with an experienced attorney to discuss your specific situation and determine if you may be eligible to file a lawsuit.
-
Does the Depo-Provera warning label say anything about brain tumors?
The Depo-Provera warning label does not currently mention brain tumors or meningiomas.
However, recent research findings could lead to updates, as some Depo-Provera lawsuits claim a connection between prolonged use and increased meningioma risk.
-
How does the Depo-Provera shot work?
The Depo-Provera shot prevents pregnancy by stopping ovulation, thickening cervical mucus to block sperm, and altering the uterine lining to prevent egg implantation.
Each injection provides effective birth control for about three months.
-
What company makes Depo-Provera?
Depo-Provera is manufactured by Pfizer, Inc., a major pharmaceutical company responsible for the drug’s production, distribution, and safety updates.
Pfizer has also been named in some Depo-Provera lawsuits due to emerging claims about potential risks associated with long-term use.
-
What are the Depo-Provera lawsuit statute of limitations?
The statute of limitations for filing a Depo-Provera shot lawsuit varies by state, usually between two to three years from the discovery of injury.
Since meningiomas can develop slowly, users affected by Depo-Provera’s risks should seek legal guidance promptly to file within the required timeframe.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Additional Depo-Provera Lawsuit resources on our website:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
